Literature DB >> 7780228

Experimental study on chemotherapy using adsorbent charcoal with CDDP administered directly into the mediastinum following esophagectomy.

K Domitsu1, S Akiyama, K Ito, K Kiriyama, Y Kodera, K Kondo, T Watanabe, H Takagi.   

Abstract

In this study, 1500AA, an activated charcoal with a strong affinity for the lymphatic system, was examined for its ability to deliver chemotherapy to metastatic lymph nodes. First, the anticancer effect on metastatic lymph nodes was assessed in an experiment using the mouse mammary tumor, MM48. Pathological examination of the inguinal lymph nodes revealed a metastatic rate of 50% in the group given cisplatin (CDDP)-saline, but 20% in the group given CDDP-charcoal. Next, in a canine model, CDDP dissolved in normal saline was administered directly into the mediastinum, and CDDP was given with fine particles of activated charcoal in the same manner in the other group. The concentration of CDDP in the lymph nodes and the plasma rapidly increased to peak in 10 min in the CDDP-saline group, whereas it increased slowly to peak in 20-30 min in the CDDP-charcoal group. Moreover, the CDDP-charcoal group was found to have a much higher concentration of CDDP in the lymph nodes than the CDDP-saline group.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7780228     DOI: 10.1007/bf01367457

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  13 in total

1.  Immunoconjugates containing novel maytansinoids: promising anticancer drugs.

Authors:  R V Chari; B A Martell; J L Gross; S B Cook; S A Shah; W A Blättler; S J McKenzie; V S Goldmacher
Journal:  Cancer Res       Date:  1992-01-01       Impact factor: 12.701

2.  Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate.

Authors:  L M Weiner; J O'Dwyer; J Kitson; R L Comis; A E Frankel; R J Bauer; M S Konrad; E S Groves
Journal:  Cancer Res       Date:  1989-07-15       Impact factor: 12.701

3.  A phase I/II study of intraperitoneally administered doxorubicin entrapped in cardiolipin liposomes in patients with ovarian cancer.

Authors:  G Delgado; R K Potkul; J A Treat; G S Lewandowski; J F Barter; D Forst; A Rahman
Journal:  Am J Obstet Gynecol       Date:  1989-04       Impact factor: 8.661

4.  A newly developed drug delivery system using fine particles of activated charcoal for targeting chemotherapy.

Authors:  K Ito; K Kiriyama; T Watanabe; M Yamauchi; S Akiyama; K Kondou; H Takagi
Journal:  ASAIO Trans       Date:  1990 Jul-Sep

5.  Acute renal failure after cis-dichlorodiammineplatinum(II) and gentamicin-cephalothin therapies.

Authors:  J C Gonzalez-Vitale; D M Hayes; E Cvitkovic; S S Sternberg
Journal:  Cancer Treat Rep       Date:  1978-05

6.  Antitumor effect of 2'-deoxy-5-fluorouridine conjugates against a murine thymoma and colon carcinoma xenografts.

Authors:  K G Krauer; I F McKenzie; G A Pietersz
Journal:  Cancer Res       Date:  1992-01-01       Impact factor: 12.701

7.  In vitro and in vivo studies with anionic sulfatide-liposomes containing adriamycin.

Authors:  G Cervato; P Viani; I Galatulas; R Bossa; B Cestaro
Journal:  Anticancer Res       Date:  1986 Nov-Dec       Impact factor: 2.480

8.  Antitumor activity and toxicity of serum protein-bound platinum formed from cisplatin.

Authors:  K Takahashi; T Seki; K Nishikawa; S Minamide; M Iwabuchi; M Ono; S Nagamine; H Horinishi
Journal:  Jpn J Cancer Res       Date:  1985-01

9.  Tumor localization and in vivo antitumor activity of the immunoconjugate composed of anti-human colon cancer monoclonal antibody and mitomycin C-dextran conjugate.

Authors:  A Noguchi; T Takahashi; T Yamaguchi; K Kitamura; Y Takakura; M Hashida; H Sezaki
Journal:  Jpn J Cancer Res       Date:  1991-02

10.  Efficacy and specificity of a monoclonal antibody-drug conjugate in chemotherapy by intratumoral injection.

Authors:  K Kitamura; T Takahashi; T Miyagaki; N Yamaoka; H Tsurumi; E Ohtsuji; M Kamiguchi; A Noguchi; T Yamaguchi
Journal:  Jpn J Cancer Res       Date:  1992-07
View more
  1 in total

1.  Phase II trial of 5-fluorouracil and low-dose cisplatin in patients with squamous cell carcinoma of the esophagus.

Authors:  H Sekiguchi; S Akiyama; M Fujiwara; H Nakamura; K Kondo; Y Kasai; K Ito; J Sakamoto; H Takagi
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.